scout
|Videos|October 28, 2016

How Mutation Status Affects Individualization of Treatment in mCRC

Maria Ignez Braghiroli, MD, medical oncologist, Instituto do Câncer do Estado de São Paulo, discusses how mutation status effects individualization of treatment in metastatic colorectal cancer (mCRC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME